(Q44567637)

4 December 2017

Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. (English)

1 reference

4 December 2017

0 references

13

Armando Isibasi

0 references

author name string

Ingeborg Becker

1

1 reference

4 December 2017

Norma Salaiza

2

1 reference

4 December 2017

Magdalena Aguirre

3

1 reference

4 December 2017

José Delgado

4

1 reference

4 December 2017

Nuria Carrillo-Carrasco

5

1 reference

4 December 2017

Laila Gutiérrez Kobeh

6

1 reference

4 December 2017

Adriana Ruiz

7

1 reference

4 December 2017

Rocely Cervantes

8

1 reference

4 December 2017

Armando Pérez Torres

9

1 reference

4 December 2017

Nallely Cabrera

10

1 reference

4 December 2017

Augusto González

11

1 reference

4 December 2017

Carmen Maldonado

12

1 reference

4 December 2017

Armando Isibasi

13

1 reference

4 December 2017

1 August 2003

1 reference

Molecular and Biochemical Parasitology

4 December 2017

1 reference

4 December 2017

130

1 reference

4 December 2017

65-74

1 reference

4 December 2017

2

1 reference

Innate immunity: impact on the adaptive immune response

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Innate immunity: the virtues of a nonclonal system of recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Leishmania virulence: it's a knock out!

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

The lipophosphoglycan of Leishmania parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

The role of phosphoglycans in Leishmania-sand fly interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

The role of natural killer cells in host-parasite interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Early parasite containment is decisive for resistance to Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Turning on natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Perforin: more than just an effector molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Human NK-cell receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Cytotoxicity in human mucosal and cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Exploitation of the complement system by Leishmania promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Regulation of toll-like receptor 2 expression by macrophages following Mycobacterium avium infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

Requirement for type 2 NO synthase for IL-12 signaling in innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2803%2900160-9

7 January 2021

10.1016/S0166-6851(03)00160-9

Identifiers

DOI

1 reference

4 December 2017

1 reference